Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

300 cirrhosis patients join study to uncover hidden triggers of liver cancer

NCT ID NCT07119957

First seen Jun 19, 2026 · Last updated Jun 19, 2026

Summary

This study is collecting blood, urine, and stool samples from 300 people with cirrhosis to build a biobank. Researchers will later use these samples to understand how factors like nutrition, physical activity, smoking, alcohol, and pollution influence the development of the most common type of liver cancer (HCC). The goal is to identify what pushes some cirrhosis patients toward cancer, which remains largely unknown.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSES, LIVER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Angers University Hospital

    RECRUITING

    Angers, 49000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centre Eugène Marquis (Oncology center)

    NOT_YET_RECRUITING

    Rennes, 35000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rennes University Hospital, Hepatogastroenteroly Department

    NOT_YET_RECRUITING

    Rennes, 35000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tours University Hospital, HepatoGastroenterology Department

    NOT_YET_RECRUITING

    Tours, 37170, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

cirrhosis of liver hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.